Zhendong Chen

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Venues

Nature medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jin Li, Zhendong Chen, Yuxian Bai, Bo Liu, Qingshan Li, Jingdong Zhang, Jun Zhou, Ting Deng, Fuyou Zhou, Shegan Gao, Shujun Yang, Feng Ye, Long Chen, Wei Bai, Xianli Yin, Shundong Cang, Lianke Liu, Yueyin Pan, Hui Luo, Yanxia Ji, Zhen Zhang, Jufeng Wang, Quanliang Yang, Na Li, Rong Huang, Chenglin Qu, Jing Ni, Bo Wang, Yan Xu, Jin Hu, Qingmei Shi, Jason Yang
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study. Nature medicine (2024)
Jin Li, Zhendong Chen, Yuxian Bai, Bo Liu, Qingshan Li, Jingdong Zhang, Jun Zhou, Ting Deng, Fuyou Zhou, Shegan Gao, Shujun Yang, Feng Ye, Long Chen, Wei Bai, Xianli Yin, Shundong Cang, Lianke Liu, Yueyin Pan, Hui Luo, Yanxia Ji, Zhen Zhang, Jufeng Wang, Quanliang Yang, Na Li, Rong Huang, Chenglin Qu, Jing Ni, Bo Wang, Yan Xu, Jin Hu, Qingmei Shi, Jason Yang
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study. Nature medicine 30 (3) (2024)
Jin Li, Zhendong Chen, Yuxian Bai, Bo Liu, Qingshan Li, Jingdong Zhang, Jun Zhou, Ting Deng, Fuyou Zhou, Shegan Gao, Shujun Yang, Feng Ye, Long Chen, Wei Bai, Xianli Yin, Shundong Cang, Lianke Liu, Yueyin Pan, Hui Luo, Yanxia Ji, Zhen Zhang, Jufeng Wang, Quanliang Yang, Na Li, Rong Huang, Chenglin Qu, Jing Ni, Bo Wang, Yan Xu, Jin Hu, Qingmei Shi, Jason Yang
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study. Nature medicine 30 (3) (2024)
Jin Li, Zhendong Chen, Yuxian Bai, Bo Liu, Qingshan Li, Jingdong Zhang, Jun Zhou, Ting Deng, Fuyou Zhou, Shegan Gao, Shujun Yang, Feng Ye, Long Chen, Wei Bai, Xianli Yin, Shundong Cang, Lianke Liu, Yueyin Pan, Hui Luo, Yanxia Ji, Zhen Zhang, Jufeng Wang, Quanliang Yang, Na Li, Rong Huang, Chenglin Qu, Jing Ni, Bo Wang, Yan Xu, Jin Hu, Qingmei Shi, Jason Yang
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study. Nature medicine 30 (3) (2024)
Jin Li, Zhendong Chen, Yuxian Bai, Bo Liu, Qingshan Li, Jingdong Zhang, Jun Zhou, Ting Deng, Fuyou Zhou, Shegan Gao, Shujun Yang, Feng Ye, Long Chen, Wei Bai, Xianli Yin, Shundong Cang, Lianke Liu, Yueyin Pan, Hui Luo, Yanxia Ji, Zhen Zhang, Jufeng Wang, Quanliang Yang, Na Li, Rong Huang, Chenglin Qu, Jing Ni, Bo Wang, Yan Xu, Jin Hu, Qingmei Shi, Jason Yang
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study. Nature medicine (2024)
Jin Li, Zhendong Chen, Yuxian Bai, Bo Liu, Qingshan Li, Jingdong Zhang, Jun Zhou, Ting Deng, Fuyou Zhou, Shegan Gao, Shujun Yang, Feng Ye, Long Chen, Wei Bai, Xianli Yin, Shundong Cang, Lianke Liu, Yueyin Pan, Hui Luo, Yanxia Ji, Zhen Zhang, Jufeng Wang, Quanliang Yang, Na Li, Rong Huang, Chenglin Qu, Jing Ni, Bo Wang, Yan Xu, Jin Hu, Qingmei Shi, Jason Yang
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study. Nature medicine 30 (3) (2024)
Jin Li, Zhendong Chen, Yuxian Bai, Bo Liu, Qingshan Li, Jingdong Zhang, Jun Zhou, Ting Deng, Fuyou Zhou, Shegan Gao, Shujun Yang, Feng Ye, Long Chen, Wei Bai, Xianli Yin, Shundong Cang, Lianke Liu, Yueyin Pan, Hui Luo, Yanxia Ji, Zhen Zhang, Jufeng Wang, Quanliang Yang, Na Li, Rong Huang, Chenglin Qu, Jing Ni, Bo Wang, Yan Xu, Jin Hu, Qingmei Shi, Jason Yang
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study. Nature medicine (2024)
Yan-Song Lin, Shu-Kui Qin, Hui Yang, Feng Shi, Aimin Yang, Xingmin Han, Bin Liu, Zhiyong Li, Qinghai Ji, Lijun Tang, Zhiyong Deng, Yong Ding, Wei Fu, Xianhe Xie, Linfa Li, Xiaohui He, Zhongwei Lv, Qingjie Ma, Zan Shen, Zhuming Guo, Zhendong Chen, Yali Cui, Jian Tan, Zairong Gao, Shanghua Jing, Keyi Lu, Xianyang Luo, Yuan Zhang, Yong Fang, Zhendong Li, Yizhuang Cheng, Shangtong Lei, Sha Luan, Guang Chen, Guihua Wang, Liqing Wu, Lingling Liu
Multicenter randomized double-blind phase III trial of donafenib in progressive radioactive iodine-refractory differentiated thyroid cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Shu-Kui Qin, Jin Li, Yuxian Bai, Zishu Wang, Zhendong Chen, Rui-Hua Xu, Jian-Ming Xu, Hong-Mei Zhang, Jia Chen, Ying Yuan, Tianshu Liu, Lin Yang, Haijun Zhong, Donghui Chen, Lin Shen, Chunyi Hao, Deliang Fu, Ying Cheng, Jianwei Yang, Qiong Wang, Baoli Qin, Hongming Pan, Jun Zhang, Xianhong Bai, Qingshan Zheng
Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

Zhendong Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhendong Chen